Clinical Trial Update: Effect of Melatonin on Cardiovascular and Muscle Mass and Function in Patients With Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effect of melatonin on cardiovascular outcomes and muscle mass/function in patients with heart failure with reduced eje…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 2 | Status: UNKNOWN